Form 8-K - Current report:
SEC Accession No. 0001104659-21-149321
Filing Date
2021-12-14
Accepted
2021-12-14 06:01:24
Documents
12
Period of Report
2021-12-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2135341d1_8k.htm   iXBRL 8-K 23805
  Complete submission text file 0001104659-21-149321.txt   195393

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ttnp-20211213.xsd EX-101.SCH 3031
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttnp-20211213_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttnp-20211213_pre.xml EX-101.PRE 22363
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2135341d1_8k_htm.xml XML 3611
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 211489587
SIC: 2836 Biological Products, (No Diagnostic Substances)